Follow
Thomas J. Ettrich
Thomas J. Ettrich
Attending physician, Ulm University Hospital
Verified email at uniklinik-ulm.de
Title
Cited by
Cited by
Year
FOLFOXIRI plus panitumumab as first-line treatment of RAS wild-type metastatic colorectal cancer: the randomized, open-label, phase II VOLFI study (AIO KRK0109)
MD Swen Wessendorf, MD Thomas Ettrich, MD Stephan Kanzler, ...
J Clin Oncol 37, 3401-3411, 2020
1782020
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study
O Türeci, U Sahin, H Schulze-Bergkamen, Z Zvirbule, F Lordick, ...
Annals of Oncology 30 (9), 1487-1495, 2019
1532019
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113 …
V Kunzmann, JT Siveke, H Algül, E Goekkurt, G Siegler, U Martens, ...
The Lancet Gastroenterology & Hepatology 6 (2), 128-138, 2021
1222021
Regorafenib
TJ Ettrich, T Seufferlein
Small Molecules in Oncology, 45-56, 2018
1172018
Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA …
RD Hofheinz, GM Haag, TJ Ettrich, K Borchert, A Kretzschmar, ...
Journal of Clinical Oncology 38 (15_suppl), 4502-4502, 2020
882020
Surgical and pathological outcome, and pathological regression, in patients receiving perioperative atezolizumab in combination with FLOT chemotherapy versus FLOT alone for …
SE Al-Batran, S Lorenzen, PC Thuss-Patience, N Homann, M Schenk, ...
Journal of Clinical Oncology 40 (16_suppl), 4003-4003, 2022
842022
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
TJ Ettrich, D Schwerdel, A Dolnik, F Beuter, TJ Blätte, SA Schmidt, ...
Scientific reports 9 (1), 13261, 2019
802019
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer-the NEONAX trial (AIO-PAK-0313), a prospective, randomized …
TJ Ettrich, AW Berger, L Perkhofer, S Daum, A König, A Dickhut, U Wittel, ...
BMC cancer 18, 1-10, 2018
702018
Treatment of pancreatic cancer—neoadjuvant treatment in resectable pancreatic cancer (PDAC)
T Seufferlein, TJ Ettrich
Translational gastroenterology and hepatology 4, 2019
672019
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal …
M Moehler, A Maderer, PC Thuss-Patience, B Brenner, J Meiler, TJ Ettrich, ...
Annals of Oncology 31 (2), 228-235, 2020
662020
Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo …
JC Stingl, T Ettrich, R Muche, M Wiedom, J Brockmöller, A Seeringer, ...
BMC cancer 11, 1-9, 2011
632011
Pancreatic cancer-derived organoids–a disease modeling tool to predict drug response
PO Frappart, K Walter, J Gout, AK Beutel, M Morawe, F Arnold, M Breunig, ...
United European Gastroenterology Journal 8 (5), 594-606, 2020
572020
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial (AIO-KRK …
A Stein, M Binder, E Goekkurt, S Lorenzen, J Riera-Knorrenschild, ...
Journal of Clinical Oncology 38 (4_suppl), 96-96, 2020
552020
A blood-based multi marker assay supports the differential diagnosis of early-stage pancreatic cancer
AW Berger, D Schwerdel, A Reinacher-Schick, W Uhl, H Algül, H Friess, ...
Theranostics 9 (5), 1280, 2019
532019
Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA
AW Berger, D Schwerdel, H Welz, R Marienfeld, SA Schmidt, A Kleger, ...
PloS one 12 (3), e0174308, 2017
532017
Targeted deep sequencing of circulating tumor DNA in metastatic pancreatic cancer
AW Berger, D Schwerdel, TJ Ettrich, A Hann, SA Schmidt, A Kleger, ...
Oncotarget 9 (2), 2076, 2018
462018
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—A randomized phase II trial of the AIO pancreatic cancer group
T Seufferlein, W Uhl, M Kornmann, H Algül, H Friess, A König, M Ghadimi, ...
Annals of Oncology 34 (1), 91-100, 2023
452023
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label …
S Qin, M Chen, AL Cheng, AO Kaseb, M Kudo, HC Lee, AC Yopp, J Zhou, ...
The Lancet 402 (10415), 1835-1847, 2023
412023
Systemic therapy for metastatic pancreatic cancer
TJ Ettrich, T Seufferlein
Current treatment options in oncology 22 (11), 106, 2021
412021
Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers
F Finkelmeier, C Czauderna, L Perkhofer, TJ Ettrich, J Trojan, ...
Journal of cancer research and clinical oncology 145, 253-259, 2019
412019
The system can't perform the operation now. Try again later.
Articles 1–20